http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6069014-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13acffa0e4ce30d3be128ccd86b384f6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 1983-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9b562aa066228cb784bb4aa7b85dbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85bc5f0e2657b8fc1d84153e03eb90e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee37743706f9bb906db217ce51231704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18f1fbf9bdf36770ae161041b3b3061a
publicationDate 1985-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6069014-A
titleOfInvention Patch for curing dermatopathy
abstract PURPOSE: The titled preparation that is formed by laminating a clear, pressure- sensitive adhesive layer containing psoralen or its derivative and an ultraviolet abosorber, thus being suitably used for treatimg dermatopathy with beams with reduced side-effects and simple aftertreatment on a clear support. n CONSTITUTION: The titled preparation is obtained by laminating a clear adhesive layer containing psoralen or its derivative such as 8-methoxypsoralen or 4,5'- trioxypsoralen and an ultraviolet absorber such as guaiazulene or camazulene on the transparent support layer. As the clear support, is mentioned, e.g., polypropylene which permeates UVA effective for treatment, preferably more than 50%. The adhesive is also desired to have transparency of the same level as in the support layer and such a cohesion as the adhesive layer is peeled off with no adhesive remaining on the skin after treatment, being, e.g., polymers from (meth)acrylic alkyl esters. n COPYRIGHT: (C)1985,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7622136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1328259-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004512286-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8075911-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9005653-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012080969-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2968929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005027859-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1269999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9205059-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8999379-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9095691-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8057785-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1269999-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8663680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8668925-B2
priorityDate 1983-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5846017-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7274

Total number of triples: 44.